Cargando…
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
SIMPLE SUMMARY: The accumulation of senescent cells is now widely known to be a driver of aging and many age-related pathologies, such as neurodegeneration and type 2 diabetes, among others. Targeting senescent cells for selective removal or altering the proteins they release are promising therapeut...
Autores principales: | Dey, Amit K., Banarjee, Reema, Boroumand, Mozhgan, Rutherford, Delaney V., Strassheim, Quinn, Nyunt, Thedoe, Olinger, Bradley, Basisty, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604147/ https://www.ncbi.nlm.nih.gov/pubmed/37887011 http://dx.doi.org/10.3390/biology12101301 |
Ejemplares similares
-
Senotherapeutics in Cancer and HIV
por: Sánchez-Díaz, Laura, et al.
Publicado: (2022) -
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
por: Rossi, Martina, et al.
Publicado: (2021) -
Quantification and Identification of Post-Translational Modifications Using Modern Proteomics Approaches
por: Holtz, Anja, et al.
Publicado: (2021) -
Senotherapeutics and Their Molecular Mechanism for Improving Aging
por: Park, Jooho, et al.
Publicado: (2022) -
Senotherapeutics: emerging strategy for healthy aging and age-related disease
por: Kim, Eok-Cheon, et al.
Publicado: (2019)